EXEGET
Description
Exemestane is the latest in the family of aromatase inhibitors which provide the convenience of long-term oral therapy in a large sub-group of breast cancer patients.
Indications:- For adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy
- For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy
| Generic Name | Strength | Standard | Type | Packing | Pack Size |
| Exemestane | 25 mg | IP | Tab. | Strip | 1x10s |